top of page

BIA-ALCL Profile Registry



The U.S. Food and Drug Administration (FDA) specifically recommends that all confirmed cases of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) be reported to the PROFILE registry by your physician. The PROFILE registry is a joint effort of the FDA and ASPS/PSF. If you have been diagnosed with BIA-ALCL, please ensure your physician has reported the case to the PROFILE registry for tracking of cases. Information reported to PROFILE is updated with the FDA on a monthly basis.


As of July 30, 2019 - PROFILE is currently only open to physicians practicing in the United States, with plans to accept international cases in the near future. Please check the website for future updates.





All posts are intended strictly for educational purposes. It is not intended to make any representations or warranties about the outcome of any procedure. It is not a substitute for a thorough in-person consultation with a medical professional. If you have questions about your personal medical situation, please call your healthcare provider.

Comentarios


bottom of page